NeuroPace Inc (NPCE) stock
NPCENasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/3028% above fair value
$8.22+0.02 (+0.24%)
Close on Nov 18, 2026Market cap $282.15MP/E –Yield 0.00%
NeuroPace shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
NeuroPace's shares outstanding was 34M at Jun 30, 2026. For fiscal 2025 it was 33M, up 12.3% from the year before. The highest annual figure on record is 33M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 33M | +12.3% |
| FY2024 | Dec 31, 2024 | 29M | +12.7% |
| FY2023 | Dec 31, 2023 | 26M | +5.1% |
| FY2022 | Dec 31, 2022 | 25M | +48.1% |
| FY2021 | Dec 31, 2021 | 17M | +8038.9% |
| FY2020 | Dec 31, 2020 | 0M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 34M | +3.8% |
| Q1 FY2026 | Mar 31, 2026 | 34M | +7.1% |
| Q4 FY2025 | Dec 31, 2025 | 33M | +11.6% |
| Q3 FY2025 | Sep 30, 2025 | 33M | +12.5% |
| Q2 FY2025 | Jun 30, 2025 | 33M | +13.9% |
| Q1 FY2025 | Mar 31, 2025 | 31M | +11.3% |
| Q4 FY2024 | Dec 31, 2024 | 30M | +11.6% |
| Q3 FY2024 | Sep 30, 2024 | 29M | +13.2% |
| Q2 FY2024 | Jun 30, 2024 | 29M | +13.3% |
| Q1 FY2024 | Mar 31, 2024 | 28M | +12.7% |
| Q4 FY2023 | Dec 31, 2023 | 27M | +8.0% |
| Q3 FY2023 | Sep 30, 2023 | 26M | +5.2% |
| Q2 FY2023 | Jun 30, 2023 | 25M | +4.0% |
| Q1 FY2023 | Mar 31, 2023 | 25M | +3.2% |
| Q4 FY2022 | Dec 31, 2022 | 25M | +2.4% |
| Q3 FY2022 | Sep 30, 2022 | 25M | +2.6% |
| Q2 FY2022 | Jun 30, 2022 | 25M | +39.6% |
| Q1 FY2022 | Mar 31, 2022 | 24M | +8930.3% |
| Q4 FY2021 | Dec 31, 2021 | 24M | +11495.6% |
| Q3 FY2021 | Sep 30, 2021 | 24M | +11807.3% |
| Q2 FY2021 | Jun 30, 2021 | 18M | +8573.0% |
| Q1 FY2021 | Mar 31, 2021 | 0M | +33.0% |
| Q4 FY2020 | Dec 31, 2020 | 0M | – |
| Q3 FY2020 | Sep 30, 2020 | 0M | – |
| Q2 FY2020 | Jun 30, 2020 | 0M | – |
| Q1 FY2020 | Mar 31, 2020 | 0M | – |
See a number that looks wrong?